ArticleMolecules (Basel, Switzerland)2021

Prodigiosin Sensitizes Sensitive and Resistant Urothelial Carcinoma Cells to Cisplatin Treatment.

Lena Berning et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.